• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜色素变性:了解临床表现、发病机制及治疗选择。

Retinitis pigmentosa: understanding the clinical presentation, mechanisms and treatment options.

作者信息

Kalloniatis Michael, Fletcher Erica L

机构信息

Department of Optometry and Vision Science, University of Auckland, Private Bag 92019, Auckland, New Zealand.

出版信息

Clin Exp Optom. 2004 Mar;87(2):65-80. doi: 10.1111/j.1444-0938.2004.tb03152.x.

DOI:10.1111/j.1444-0938.2004.tb03152.x
PMID:15040773
Abstract

Retinitis pigmentosa (RP) is a leading cause of human blindness due to degeneration of retinal photoreceptor cells. Causes of retinal degeneration include defects in the visual pigment, defects in the proteins important for photoreceptor function or in enzymes involved in initiating visual transduction. Despite the diversity of genetic mutations identified in inherited forms of retinal dystrophy, there is a common end result of photoreceptor death and functional blindness. In this review, pertinent anatomical and physiological pathways involved in RP and the underlying genetic mutations are outlined, including a discussion on the inheritance patterns revealed by advances in molecular biological techniques. Characteristics of progression rates of visual field loss and current management options will provide useful clinical guidelines for the management of patients with RP.

摘要

视网膜色素变性(RP)是导致人类失明的主要原因之一,是由视网膜光感受器细胞变性引起的。视网膜变性的原因包括视觉色素缺陷、对光感受器功能重要的蛋白质缺陷或参与启动视觉转导的酶缺陷。尽管在遗传性视网膜营养不良中发现了多种基因突变,但最终都会导致光感受器死亡和功能性失明。在这篇综述中,概述了与视网膜色素变性相关的相关解剖学和生理学途径以及潜在的基因突变,包括对分子生物学技术进展所揭示的遗传模式的讨论。视野丧失的进展速度特征和当前的治疗选择将为视网膜色素变性患者的管理提供有用的临床指导。

相似文献

1
Retinitis pigmentosa: understanding the clinical presentation, mechanisms and treatment options.视网膜色素变性:了解临床表现、发病机制及治疗选择。
Clin Exp Optom. 2004 Mar;87(2):65-80. doi: 10.1111/j.1444-0938.2004.tb03152.x.
2
Non-syndromic retinitis pigmentosa.非综合征性视网膜色素变性。
Prog Retin Eye Res. 2018 Sep;66:157-186. doi: 10.1016/j.preteyeres.2018.03.005. Epub 2018 Mar 27.
3
Retinitis pigmentosa inversa.逆性色素性视网膜炎
Optom Vis Sci. 1998 Aug;75(8):560-70. doi: 10.1097/00006324-199808000-00021.
4
Retinitis pigmentosa.视网膜色素变性
Orphanet J Rare Dis. 2006 Oct 11;1:40. doi: 10.1186/1750-1172-1-40.
5
Review and update: current treatment trends for patients with retinitis pigmentosa.综述与更新:视网膜色素变性患者的当前治疗趋势
Optometry. 2009 Jul;80(7):384-401. doi: 10.1016/j.optm.2008.01.026.
6
[Retinitis pigmentosa - a review. Pathogenesis, guidelines for diagnostics and perspectives].[色素性视网膜炎——综述。发病机制、诊断指南及展望]
Ophthalmologe. 2012 May;109(5):501-14;quiz 515. doi: 10.1007/s00347-012-2555-6.
7
[Clinical practice guidelines for retinitis pigmentosa].[视网膜色素变性临床实践指南]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Mar 10;37(3):295-299. doi: 10.3760/cma.j.issn.1003-9406.2020.03.012.
8
Using the rd1 mouse to understand functional and anatomical retinal remodelling and treatment implications in retinitis pigmentosa: A review.利用rd1小鼠理解视网膜色素变性中的视网膜功能和解剖重塑及治疗意义:综述
Exp Eye Res. 2016 Sep;150:106-21. doi: 10.1016/j.exer.2015.10.019. Epub 2015 Oct 30.
9
Retinitis pigmentosa: defined from a molecular point of view.视网膜色素变性:从分子角度的定义
Surv Ophthalmol. 1999 Jan-Feb;43(4):321-34. doi: 10.1016/s0039-6257(98)00046-0.
10
[Experimental therapeutic modalities for retinitis pigmentosa].[视网膜色素变性的实验性治疗方法]
Harefuah. 2004 May;143(5):368-71, 389.

引用本文的文献

1
Bridging the gap of vision restoration.弥合视力恢复的差距。
Front Cell Neurosci. 2024 Nov 21;18:1502473. doi: 10.3389/fncel.2024.1502473. eCollection 2024.
2
A novel compound heterozygous PCDH15 variants is associated with arRP in a Chinese pedigree.一个新的 PCDH15 复合杂合变异与一个中国家系中的常染色体隐性视网膜色素变性相关。
BMC Ophthalmol. 2024 Aug 26;24(1):373. doi: 10.1186/s12886-024-03640-1.
3
PRPF31-retinitis pigmentosa: Challenges and opportunities for clinical translation.PRPF31 相关性视网膜炎:临床转化的挑战与机遇。
Vision Res. 2023 Dec;213:108315. doi: 10.1016/j.visres.2023.108315. Epub 2023 Sep 14.
4
Heterogeneity in quiescent Müller glia in the uninjured zebrafish retina drive differential responses following photoreceptor ablation.未受伤斑马鱼视网膜中静止的米勒神经胶质细胞的异质性驱动了光感受器消融后的不同反应。
Front Mol Neurosci. 2023 Jul 27;16:1087136. doi: 10.3389/fnmol.2023.1087136. eCollection 2023.
5
CNG channel-related retinitis pigmentosa.CNG 通道相关性视网膜色素变性。
Vision Res. 2023 Jul;208:108232. doi: 10.1016/j.visres.2023.108232. Epub 2023 Apr 11.
6
Biology, Pathobiology and Gene Therapy of CNG Channel-Related Retinopathies.环核苷酸门控通道相关视网膜病变的生物学、病理生物学及基因治疗
Biomedicines. 2023 Jan 19;11(2):269. doi: 10.3390/biomedicines11020269.
7
Intravitreal Administration of rhNGF Enhances Regenerative Processes in a Zebrafish Model of Retinal Degeneration.玻璃体内注射重组人神经生长因子可增强视网膜变性斑马鱼模型中的再生过程。
Front Pharmacol. 2022 Mar 7;13:822359. doi: 10.3389/fphar.2022.822359. eCollection 2022.
8
Identification of a novel RHO heterozygous nonsense mutation in a Chinese family with autosomal dominant retinitis pigmentosa.一个中国常染色体显性遗传视网膜色素变性家系中发现一种新型 RHO 杂合无义突变。
BMC Ophthalmol. 2021 Oct 11;21(1):360. doi: 10.1186/s12886-021-02125-9.
9
Genome Editing for CNS Disorders.用于中枢神经系统疾病的基因组编辑
Front Neurosci. 2020 Oct 22;14:579062. doi: 10.3389/fnins.2020.579062. eCollection 2020.
10
A pathoconnectome of early neurodegeneration: Network changes in retinal degeneration.早期神经退行性病变的病理连接组学:视网膜变性中的网络变化。
Exp Eye Res. 2020 Oct;199:108196. doi: 10.1016/j.exer.2020.108196. Epub 2020 Aug 15.